Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded-criteria donors

A recently released article by Savoye et al. used the data collected by The French National Transplant Registry (CRISTAL) following the implementation of a nationwide hypothermic machine perfusion (HMP) program for extended criteria donor (ECD) kidney transplants.

The study included 4,316 transplants, 801 of which used HMP. Overall, they confirmed that even though the HMP transplant population was at higher risk for delayed graft function (DGF), HMP compared with cold storage (CS) protected against DGF (adjusted OR=0.49 with a 24% DGF rate in the HMP group versus 38% in the CS group).

Read the full article here: https://doi.org/10.1111/ctr.13536

Tagged In:

Clinical, DGF, HMP, Kidney

The Latest

Check out the most recent posts

David’s Transplant Journey

News

In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...

Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era

Clinical Evidence

A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...

Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

Clinical Evidence

In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...

Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study

News

We are proud to announce that the first livers have officially been transplanted using the LifePort®Liver Transporter as part of the PILOT™ Continued Access Study. The first livers preserved with the LLT under Continued Access were transplanted at University...